By Daniella Parra
Nanox Imaging Ltd. said that its AI Cardiac Solution (HealthCCSng) was showcased at SCCT 2024.
Corewell Health’s study showed HealthCCSng identified 3,721 new patients with significant CAC in one year, improving patient outcomes and compliance. Jefferson Einstein Hospital showed HealthCCSng identified 757 patients with high CAC, generating significant clinical and economic benefits.
Massachusetts General and Brigham & Women’s Hospitals found a correlation between CAC and lipoprotein(a), suggesting AI’s potential in identifying at-risk patients. Rabin Medical Center identified patients with severe CAC using HealthCCSng, enabling preventive cardiology interventions.
“We are encouraged by the implementation of our AI cardiac solution at esteemed healthcare systems, along with the continued validation through real-world studies of its potential to promote early detection and preventive care of cardiovascular disease,” said Erez Meltzer, Nanox Chief Executive Officer and Acting Chairman. “We would also like to thank SCCT for the opportunity to showcase the outstanding clinical results of our AI cardiac solution.”
Contact:
Editor@executives-edge.com
